financetom
Market
financetom
/
Market
/
Crude Oil Rises 1%; DermTech Shares Plummet
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crude Oil Rises 1%; DermTech Shares Plummet
Jun 18, 2024 9:22 AM

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 0.1% on Tuesday.

The Dow traded up 0.09% to 38,814.43 while the NASDAQ fell 0.01% to 17,855.89. The S&P 500 also rose, gaining, 0.19% to 5,483.50.

Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 8% Dividend Yields

Leading and Lagging Sectors

Energy shares jumped by 0.7% on Tuesday.

In trading on Tuesday, communication services shares fell by 0.7%.

Top Headline

U.S. industrial production increased 0.9% month-over-month in May, topping market estimates of a 0.3% gain.

Equities Trading UP

                       

Reliance Global Group, Inc ( RELI ). shares shot up 258% to $0.7947 after the company said it expects the pending acquisition of Spetner Associates to close in the second half of 2024, projecting it to increase annualized revenue to approximately $28 million.

Shares of Actelis Networks Inc ( ASNS ) got a boost, surging 73% to $1.99 after the IoT solutions provider disclosed its partnership with Carahsoft, a leading U.S. IT Software and Services Company.

Comtech Telecommunications Corp ( CMTL ) shares were also up, gaining 50% to $3.26 after the company announced a new $222 million credit facility.

Equities Trading DOWN

Taysha Gene Therapies Inc ( TSHA ) shares dropped 31% to $2.77 after the company announced longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial of TSHA-102 in Rett syndrome.

Shares of DermTech, Inc. ( DMTK ) were down 58% to $0.14 after the company filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.

Quantum Corporation ( QMCO ) was down, falling 47% to $0.41 following weaker-than-expected FY 2024 results.

Also Check This Out: How To Earn $500 A Month From Jabil Stock Ahead Of Q3 Earnings Report

Commodities

In commodity news, oil traded up 1.2% to $81.30 while gold traded up 0.6% at $2,342.40.

Silver traded up 0.2% to $29.44 on Tuesday, while copper rose 0.3% to $4.4615.

Euro zone

European shares were higher today. The eurozone's STOXX 600 gained 0.69%, Germany's DAX rose 0.35% and France's CAC 40 gained 0.76%. Spain's IBEX 35 Index rose 0.99%, while London's FTSE 100 climbed 0.60%.

Annual inflation rate in the Eurozone accelerated to 2.6% in May from 2.4% in the previous month, while ZEW Indicator of Economic Sentiment rose by 4.3 points to a reading of 51.3 in June.

The ZEW Indicator of Economic Sentiment for Germany rose to 47.5 in June, notching the highest reading since February 2022.

Asia Pacific Markets

Asian markets closed mostly higher on Tuesday, with Japan's Nikkei gaining 1%, Hong Kong's Hang Seng Index declining 0.11%, China's Shanghai Composite Index gaining 0.48% and India's S&P BSE Sensex gaining 0.4%.

Singapore’s non-oil domestic exports slipped 0.1% year-over-year for May versus a sharp 9.6% decline in the prior month.

Economics

U.S. retail sales rose 0.1% month-over-month in May compared to a revised 0.2% declined in April and missing market expectations of 0.2% gain.

U.S. industrial production increased 0.9% month-over-month in May, topping market estimates of a 0.3% gain.

Now Read This: $176M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regeneron Pharma's first-quarter results miss on lower Eylea demand
Regeneron Pharma's first-quarter results miss on lower Eylea demand
May 25, 2025
(Reuters) -Regeneron missed Wall Street estimates for first-quarter results on Tuesday, hurt by waning demand for its blockbuster eye disease drug Eylea, sending the company's shares tumbling 7% in premarket trading. The drugmaker has been grappling with stiff competition for Eylea from cheaper versions and rivals, including Roche's Vabysmo. Regeneron said Eylea sales were also hit by lower wholesale inventory...
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Key Economic Data, Mix of Earnings
May 25, 2025
08:18 AM EDT, 04/29/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was slightly up by 0.03% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% lower in Tuesday's premarket activity as investors await key economic data to be released later in the day, and access a mix of pharmaceutical and...
Stocks Mostly Down Pre-Bell as Investors Await Potential Auto Tariff Relief, Latest Round of Earnings
Stocks Mostly Down Pre-Bell as Investors Await Potential Auto Tariff Relief, Latest Round of Earnings
May 25, 2025
07:32 AM EDT, 04/29/2025 (MT Newswires) -- US equity futures were mostly lower on Tuesday as investors assess media reports that President Donald Trump plans to ease tariff pressure on the domestic auto industry and await the latest batch of corporate earnings. The S&P 500 slipped 0.1% while the Dow Jones Industrial Average gained 0.2% before the bell. The indexes...
US STOCKS-S&P 500, Nasdaq futures subdued as markets assess earnings, await data
US STOCKS-S&P 500, Nasdaq futures subdued as markets assess earnings, await data
May 25, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Futures: Dow up 0.26%, S&P 500 down 0.13%, Nasdaq off 0.16% * Honeywell gains after rise in Q1 profit * General Motors ( GM ) pulls forecast on tariff uncertainty * Consumer confidence, JOLTS data due in the day...
Copyright 2023-2026 - www.financetom.com All Rights Reserved